Dyne Therapeutics, Inc. · NASDAQ:DYN

ForDyne B.V.'s stake in Dyne Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

ForDyne B.V.'s stake in Dyne Therapeutics, Inc. fell to 4.80%, 5,400,545 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
4.80%
Shares
5,400,545
Intent
Passive
What changed
Fell below 5%
Filed together
5 holders

The filing in full

HolderStakeShares
ForDyne B.V.4.80%5,400,545
Forbion Capital Fund IV Cooperatief U.A.3.60%4,036,476
Forbion IV Management B.V.3.60%4,036,476
Forbion Growth Opportunities Fund II Cooperatief U.A.1.30%1,426,370
Forbion Growth II Management B.V.1.30%1,426,370

Source

View original at SEC

Related